GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹318 Cr | ₹241 Cr | ₹187 Cr | ₹137 Cr | ₹98 Cr |
What is the latest Total Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹318 Cr |
| Mar2024 | ₹241 Cr |
| Mar2023 | ₹187 Cr |
| Mar2022 | ₹137 Cr |
| Mar2021 | ₹98 Cr |
How is Total Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹318 Cr | 31.87 | |
| Mar2024 | ₹241 Cr | 29.13 | |
| Mar2023 | ₹187 Cr | 36.30 | |
| Mar2022 | ₹137 Cr | 39.37 | |
| Mar2021 | ₹98 Cr | - | |
Compare Total Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹4,725.2 Cr | 21.4% | 21.6% | 16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.4% | 6.4% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -0.9% | 5% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 1.6% | 7.6% | 38.5% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.2% | 7.7% | -3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.1% | -1.2% | 8.7% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 21.4% |
21.6% |
16.7% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses